• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血管内皮生长因子——结构与功能]

[Vascular endothelial growth factor--structure and functions].

作者信息

Barańska Patrycja, Jerczyńska Hanna, Pawłowska Zofia

机构信息

Department of Molecular and Medical Biophysics, Institute of Physiology and Biochemistry, Medical University of Lodz, 6/8 Mazowiecka St., 92-215 Lodz, Poland.

出版信息

Postepy Biochem. 2005;51(1):12-21.

PMID:16209337
Abstract

Vascular endothelial cell growth factor (VEGF), originally described as a vascular permeability factor, is currently known as one of the main factors which regulate angiogenesis. It plays an important role in the regulation of normal as well as pathological angiogenesis. In this paper we try to shortly review the actual knowledge on VEGF protein family, its expression, VEGF receptors and role of VEGF in signal transduction. The aim of this review is also to summarize recent achievements in research on biological functions of vascular endothelial growth factor and their clinical applications.

摘要

血管内皮细胞生长因子(VEGF)最初被描述为一种血管通透因子,目前被认为是调节血管生成的主要因子之一。它在正常以及病理性血管生成的调节中发挥着重要作用。在本文中,我们试图简要回顾关于VEGF蛋白家族、其表达、VEGF受体以及VEGF在信号转导中的作用的现有知识。本综述的目的还在于总结血管内皮生长因子生物学功能研究及其临床应用的最新成果。

相似文献

1
[Vascular endothelial growth factor--structure and functions].[血管内皮生长因子——结构与功能]
Postepy Biochem. 2005;51(1):12-21.
2
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.血管内皮生长因子(VEGF)/VEGF受体系统及其在生理和病理条件下的作用。
Clin Sci (Lond). 2005 Sep;109(3):227-41. doi: 10.1042/CS20040370.
3
VEGF in biological control.生物控制中的血管内皮生长因子
J Cell Biochem. 2007 Dec 15;102(6):1358-67. doi: 10.1002/jcb.21579.
4
Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.血管内皮生长因子作为肿瘤相关血管生成中的一种存活因子。
In Vivo. 2004 Sep-Oct;18(5):525-42.
5
Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.血管内皮生长因子异构体在视网膜血管生成及迪格奥尔格综合征中的作用
Verh K Acad Geneeskd Belg. 2005;67(4):229-76.
6
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.血管内皮生长因子(VEGF)及其受体在肿瘤血管生成和恶性肿瘤中的表达
Integr Cancer Ther. 2005 Dec;4(4):315-21. doi: 10.1177/1534735405282557.
7
Current insights on the biology and clinical aspects of VEGF regulation.关于血管内皮生长因子(VEGF)调控的生物学及临床方面的当前见解。
Vasc Endovascular Surg. 2008;42(6):517-30. doi: 10.1177/1538574408322755. Epub 2008 Sep 17.
8
Vascular endothelial growth factor (VEGF) in physiological and pathological conditions.生理和病理条件下的血管内皮生长因子(VEGF)
Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):8-14.
9
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.血管内皮生长因子受体在血管生成和淋巴管生成调控中的信号转导
Exp Cell Res. 2006 Mar 10;312(5):549-60. doi: 10.1016/j.yexcr.2005.11.012. Epub 2005 Dec 5.
10
[VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF].[血管内皮生长因子与年龄相关性黄斑变性。第一部分。血管内皮生长因子的生理和病理作用]
Klin Oczna. 2007;109(1-3):94-6.

引用本文的文献

1
Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy.预防性玻璃体内注射贝伐单抗对术前眼内VEGF升高的增殖性糖尿病视网膜病变患者玻璃体切除术后并发症的预防效果。
Clin Ophthalmol. 2019 Jun 28;13:1063-1070. doi: 10.2147/OPTH.S203921. eCollection 2019.
2
Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.人血浆中 VEGF-A、VEGF-C、VEGF-D 及其可溶性受体-VEGFR-2 的水平及其作为乳腺癌诊断肿瘤标志物的适用性。
Pathol Oncol Res. 2019 Oct;25(4):1477-1486. doi: 10.1007/s12253-018-0527-0. Epub 2018 Nov 1.
3
Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia.下肢慢性缺血患者超重和肥胖与血浆中血管内皮生长因子-A、可溶性血管内皮生长因子受体-1和可溶性血管内皮生长因子受体-2浓度的关系
J Zhejiang Univ Sci B. 2016;17(11):842-849. doi: 10.1631/jzus.B1600009.
4
A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus.对血糖控制良好的2型糖尿病患者体内血管内皮生长因子A、血管内皮生长因子受体1和血管内皮生长因子受体2的初步评估。
J Zhejiang Univ Sci B. 2014 Jun;15(6):575-81. doi: 10.1631/jzus.B1400024.